Primary autoimmune myelofibrosis: Definition of a distinct clinicopathologic syndrome

American Journal of Hematology

Volumn 72, Issue 1, 2003, Pages 8-12

  Pullarkat, Vinod ^a,c   Bass, Randall D ^a   Gong, Jerald Z ^b   Feinstein, Donald I ^a   Brynes, Russell K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Autoimmune myelofibrosis; Clinical features; Pathology; Treatment

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; CYTOKINE;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BLOOD; BONE MARROW; CHRONIC IDIOPATHIC MYELOFIBROSIS; CHRONICITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOPENIA; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LABORATORY TEST; LYMPHOID TISSUE; MALE; MYELOFIBROSIS; MYELOPHTHISIC ANEMIA; MYELOPROLIFERATIVE DISORDER; NEOPLASM; PATHOGENESIS; POIKILOCYTOSIS; PRIMARY AUTOIMMUNE MYELOFIBROSIS; PRIORITY JOURNAL; SHORT COURSE THERAPY; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BONE MARROW; COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; FIBROSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MEGAKARYOCYTES; MIDDLE AGED; MYELOFIBROSIS; SPLEEN; SWEATING;

EID: 0037218477     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10258     Document Type: Article

References (23)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000;342:1255-1265.
2. McCarthy DM. Fibrosis of the bone marrow: Content and causes. Br J Haematol 1985;59:1-7.
3. Matsouka C, Liouris J, Andrianakos A, Papademetriou C, Karvountzis G. Systemic lupus erythematosus and myelofibrosis. Clin Rheumatol 1989;8:402-407.
4. Paquette RL, Meshkinpour A, Rosen PJ. Autoimmune myelofibrosis: A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus. Medicine 1994;73:145-152.
5. Ramakrishna R, Kyle PW, Day PJ, Manoharan A. Evans' syndrome, myelofibrosis and systemic lupus erythematosus: Role of procollagens in myelofibrosis. Pathology 1995;27:255-259.
6. Gisser SD, Chung KB. Acute myelofibrosis in progressive systemic sclerosis: Report of a case developing during long-term chlorambucil therapy and discussion of pathogenetic factors. Am J Med 1979;67:151-154.
7. Marie I, Levesque H, Cailleux N, Lepretre S, Duval C, Tilly H, Courtois H. An uncommon association: Sjögren's syndrome and autoimmune myelofibrosis. Rheumatology 1999;38:370-371.
8. Gordon BR, Coleman M, Kohen P, Day NK. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood 1981;58:904-910.
9. Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard JF, Boivin P. Immune disorders in agnogenic myeloid metaplasia: Relations to myelofibrosis. Br J Haematol 1983;53:467-475.
10. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-1277.
11. Khumbanonda M, Horowitz HI, Eyster ME. Coombs' positive hemolytic anemia in myelofibrosis with myeloid metaplasia. Am J Med Sci 1969;258:89-93.
12. Bernhardt B, Valletta M. Lupus anticoagulant in myelofibrosis. Am J Med Sci 1976;272:229-231.
13. Cappio FC, Vigliani R, Novarino A, Camussi G, Campana D, Gavosto F. Idiopathic myelofibrosis: A possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br J Haematol 1981;49:17-21.
14. Silverstein MN, Wollaeger EE, Baggenstoss AE. Gastrointestinal and abdominal manifestations of agnogenic myeloid metaplasia. Arch Intern Med 1973;131:532-537.
15. Visani G, Finelli C, Castelli U, Petti MC, Ricci P, Vianelli N, Gianni L, Zuffa E, Aloe Spiriti MA, Latagliata R. Pileri S, Magrini U, Gugliotta L, Morra E, Bernasconi C, Mandelli F, Tura S. Myelofibrosis with myeloid metaplasia: Clinical and hematological parameters predicting survival in a series of 133 patients. Br J Haematol 1990; 75:4-9.
16. Varki A, Lottenberg R, Griffith R, Reinhard E. The syndrome of idiopathic myelofibrosis: A clinicopathologic review with emphasis on the prognostic variables predicting survival. Medicine 1983;62:353-371.
17. DiBella NJ, Silverstein MN, Hoagland HC. Effect of splenectomy on tear-drop-shaped erythrocytes in agnogenic myeloid metaplasia. Arch Int Med 1977;137:380-381.
18. Cervantes F, Pereira A, Marti JM, Feliu E. Rozman C. Bone marrow lymphoid nodules in myeloproliferative disorders: Association with the non-myelosclerotic phases of idiopathic myelofibrosis and immunological significance. Br J Haematol 1988;70:279-282.
19. Bass RD, Pullarkat V, Feinstein DI, Kaul A, Winberg CD, Brynes RK. Pathology of autoimmune myelofibrosis: A report of three cases and a review of the literature. Am J Clin Pathol 2001;116:211-216.
20. Hasselbalch H, Jans H, Nielsen PL. A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: Evidence of an autoimmune pathogenesis. Am J Hematol 1987;25:225-229.
21. Lambertenghi-Deliliers G, Orazi A, Luksch R, Annaloro C, Soligo D. Myelodysplastic syndrome with increased marrow fibrosis: A distinct clinico-pathological entity. Br J Haematol 1991;78:161-166.
22. Imbert M, Nguyen D, Sultan C. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis. Leukemia Res 1992;16:51-54.
23. Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E. The changing profile of idiopathic myelofibrosis: A comparison of the presenting features of patients diagnosed in two different decades. Eur J Haematol 1998;60:101-105.